BIOMAT Database Logo BIOMAT Database Logo

Activation of suppressor T cells by tumour cells and specific antibody. 1974

R K Gershon, and M B Mokyr, and M S Mitchell

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor

Related Publications

R K Gershon, and M B Mokyr, and M S Mitchell
Activation of idiotype-specific suppressor T cells by injection of antibody carrying a recurrent idiotype.
April 1986, Cellular immunology,
R K Gershon, and M B Mokyr, and M S Mitchell
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells.
August 1976, The Journal of experimental medicine,
R K Gershon, and M B Mokyr, and M S Mitchell
Regulation of anti-hapten antibody secretion by carrier-specific suppressor T cells.
January 1978, Advances in experimental medicine and biology,
R K Gershon, and M B Mokyr, and M S Mitchell
Modulation of cellular anti-tumour responses by tumour-specific T suppressor lymphocytes.
October 1988, Clinical and experimental immunology,
R K Gershon, and M B Mokyr, and M S Mitchell
[Activation of human CD8+ suppressor T cells by an antigen specific CD4+T cell line].
December 1988, Fukuoka igaku zasshi = Hukuoka acta medica,
R K Gershon, and M B Mokyr, and M S Mitchell
Induction of idiotype-specific suppressor T cells with antigen/antibody complexes.
June 1983, The Journal of experimental medicine,
R K Gershon, and M B Mokyr, and M S Mitchell
Characterization of efferent T suppressor cells induced by Paracoccidioides brasiliensis-specific afferent T suppressor cells.
April 1988, Infection and immunity,
R K Gershon, and M B Mokyr, and M S Mitchell
Fc-specific suppressor T cells.
January 1987, Advances in experimental medicine and biology,
R K Gershon, and M B Mokyr, and M S Mitchell
Immunoglobulin-specific suppressor T cells.
January 1987, Advances in immunology,
R K Gershon, and M B Mokyr, and M S Mitchell
Control of T cell activation by CD4+CD25+ suppressor T cells.
January 2003, Novartis Foundation symposium,
Copied contents to your clipboard!